Orphazyme will get 100th employee in 2020 - CEO looks forward to an eventful year
Orphazyme has a busy year ahead, as the company expects to hire its 100th employee and apply for approval for its first treatment in the USA and Europe. CEO Kim Stratton says it would be a "real win" to get the product approved.
BY KEVIN GRØNNEMANN, TRANSLATED BY CATHERINE BRETT
If you visit biotech hub Cobis in Copenhagen, you might notice that one company now takes up half of the fourth floor, which is a lot more space than the building's other companies - and there is a good reason for that.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Orphazyme delays its first expected approval until 2021
For abonnenter
